Sanofi in Ukraine could return to realization of production localization investment projects in 2016
Sanofi international pharmaceutical company could return to the realization of production localization investment projects in 2016, Sanofi CEO for Ukraine and Belarus Jean-Paul Scheuer has said.
"Ukraine will become more attractive for investors. In particular, we started investing in the country and the production of four our medicines was localized. Despite the fact that in the past 18 months we slightly suspended the projects, we plan to return to them. We hope that in 2016," he said in an interview with Interfax-Ukraine.
Sanofi focuses on solutions for diabetes, human vaccines, innovative drugs, consumer health care, emerging markets, animal health, and is also engaged in the development and implementation of advanced technologies for the treatment of life-threatening diseases.
Advertising
Advertising
MORE ABOUT
Sanofi supplies entire planned volume of flu vaccines in current epidemic season
17:00, 05.11.2025
Sanofi, Into-Sana medical center network announce strategic partnership
14:14, 18.07.2025
Proposed requirement for disclosure of marketing agreements causes surprise among intl pharma community – Sanofi
18:37, 06.06.2025
Ministry of Health in 2023 reduces number of drugs purchased through MAA mechanism - Sanofi
13:22, 19.04.2024
Sanofi pharma's humanitarian aid to Ukraine is almost UAH 1.5 bln since beginning of war
17:31, 12.06.2023
LATEST
Kernel plans to invest in green energy, interested in bioethanol production, logistics
20:56, 30.01.2026
Kyivstar conducts a $131.3 mln SPO with upside to $150.9 mln, shares fall 6.6%
20:53, 30.01.2026
Kernel switches production of Shchedry Dar, Stozhar bottled oil to green energy from sunflower husks
18:01, 30.01.2026
Cabinet expands coverage under business war risk insurance program, simplifies application submission – Svyrydenko
14:10, 30.01.2026
EU allocates EUR 10 mln for development of digital services in Ukraine – ministry